ES402536A1 - Procedimiento para la preparacion de alcaloides de tipo readanico. - Google Patents

Procedimiento para la preparacion de alcaloides de tipo readanico.

Info

Publication number
ES402536A1
ES402536A1 ES402536A ES402536A ES402536A1 ES 402536 A1 ES402536 A1 ES 402536A1 ES 402536 A ES402536 A ES 402536A ES 402536 A ES402536 A ES 402536A ES 402536 A1 ES402536 A1 ES 402536A1
Authority
ES
Spain
Prior art keywords
translation
procedure
preparation
machine
lower alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES402536A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES402536A1 publication Critical patent/ES402536A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES402536A 1971-05-10 1972-05-09 Procedimiento para la preparacion de alcaloides de tipo readanico. Expired ES402536A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14197971A 1971-05-10 1971-05-10
US16658271A 1971-07-27 1971-07-27

Publications (1)

Publication Number Publication Date
ES402536A1 true ES402536A1 (es) 1975-11-01

Family

ID=26839631

Family Applications (1)

Application Number Title Priority Date Filing Date
ES402536A Expired ES402536A1 (es) 1971-05-10 1972-05-09 Procedimiento para la preparacion de alcaloides de tipo readanico.

Country Status (8)

Country Link
AR (1) AR192246A1 (es)
AU (2) AU4207072A (es)
BE (2) BE783189A (es)
DE (2) DE2222716A1 (es)
ES (1) ES402536A1 (es)
FR (2) FR2137627A1 (es)
IL (2) IL39381A0 (es)
NL (2) NL7206203A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
JPH0681745B2 (ja) * 1986-01-16 1994-10-19 シェリング・コ−ポレ−ション 縮合ベンゾアゼピン
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines

Also Published As

Publication number Publication date
IL39380A0 (en) 1972-07-26
NL7206204A (es) 1972-11-14
AR192246A1 (es) 1973-02-08
IL39381A0 (en) 1972-07-26
AU4207172A (en) 1973-11-15
BE783188A (fr) 1972-11-09
FR2137626A1 (en) 1972-12-29
BE783189A (fr) 1972-11-09
AU4207072A (en) 1973-11-15
DE2222715A1 (de) 1972-11-23
NL7206203A (es) 1972-11-14
DE2222716A1 (de) 1972-11-23
FR2137627A1 (es) 1972-12-29

Similar Documents

Publication Publication Date Title
ES307302A1 (es) Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.
ES387016A1 (es) Un procedimiento para la preparacion de derivado de isoqui-nolina.
ES432952A1 (es) Procedimiento para preparar derivado de vincamina.
ES402536A1 (es) Procedimiento para la preparacion de alcaloides de tipo readanico.
GB1122104A (en) Novel diazo compounds and diazotype copying material
ES325146A1 (es) Un procedimiento para la preparacion de aminoisoxazoles.
ES419019A1 (es) Procedimiento para la preparacion de compuestos polici- clicos.
ES283396A1 (es) Procedimiento para la fabricación de derivados de tetrahidroisoquinolina
ES317623A1 (es) Un procedimiento para la preparacion de compuestos heterociclicos.
ES394885A1 (es) Un procedimiento para preparar derivados de acido fluoreno-2-acetico.
ES401898A1 (es) Procedimiento para la preparacion de derivados de benzofu- rano.
ES395391A1 (es) Procedimiento para preparar nuevos derivados de ftalacina.
ES363002A1 (es) Procedimiento para la obtencion de un medio fungitoxico.
ES393107A1 (es) Procedimiento para la preparacion de cianuros de diazonio.
ES327297A1 (es) Procedimiento para la obtencion de compuestos derivados de la quinazolina.
ES417230A1 (es) Procedimiento para la preparacion de una nueva sal de accion psicotonica.
ES398613A1 (es) Procedimiento para la preparacion de nuevas 1-sustituido - 2 -oxi -2,3 - dihidro- 5 -aril - 1h - 1,4 - benzodiacepinas.
GB1106865A (en) Light-sensitive piperazinyl-benzene diazonium salts
ES285360A1 (es) Procedimiento para la preparación de compuestos tricíclicos
ES305738A1 (es) Procedimiento para la preparacion de nuevos 5-fenil-6,7-benzomorfanos sustituidos.
ES416480A1 (es) Procedimiento para la obtencion de derivados del benzocic- loheptatiofeno.
ES423146A1 (es) Procedimiento para la preparacion de nuevas 2 - alcohilmer-capto - 5 - fenil - 4h - 3,5 - benzodiazepin - 4 - onas.
ES405281A1 (es) Un procedimiento para preparar nuevos compuestos de cefa- losporina.
ES444483A1 (es) Un procedimiento de preparacion de nuevos derivados de acido2,3-alquilen (inferior) penam-3-carboxilico.
ES382147A1 (es) Un procedimiento para preparar compuestos de morfolina n- sustituidos.